Kohlberg Kravis Roberts & Co. L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001399770

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 55 positions · Total reported value $2.62B · Top-10 concentration 87.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 11 new · 10 cut · 8 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +9.5% · vs SPY +7.4% · Prev Value $4.57B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +10.9% · vs SPY +8.7% · Latest Value $4.26B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Kohlberg Kravis Roberts & Co. L.P. disclosed 55 equity positions with a combined reported value of $2.62B. The filing implies a focused portfolio: its ten largest positions account for 87.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were BBIO ($819.08M), BV ($392.41M), FSK ($335.09M). By sector, the heaviest allocations are Health Care 35.0%, Consumer Staples 15.0%.

Versus the prior quarter, Kohlberg Kravis Roberts & Co. L.P. opened 11 new positions, trimmed 10 and fully exited 8, a turnover rate of 33.3% of positions.

The largest new positions opened in Q3 2023 were BBIO ($819.08M), BV ($392.41M), FSK ($335.09M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • BBIO BRIDGEBIO PHARMA INC · $819.08M
  • BV BRIGHTVIEW HLDGS INC · $392.41M
  • FSK FS KKR CAP CORP · $335.09M
  • APP APPLOVIN CORP · $177.82M
  • PGRU PROPERTYGURU GROUP LTD · $159.16M
  • KREF KKR REAL ESTATE FIN TR INC · $118.70M
  • EDR ENDEAVOR GROUP HOLDINGS INC CLASS · $89.47M
  • JBLU JETBLUE AIRWAYS CORP · $71.30M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Kohlberg Kravis Roberts & Co. L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

KKR (Kohlberg Kravis Roberts & Co.) was founded in 1976 by Jerome Kohlberg Jr. and cousins Henry Kravis and George Roberts after they left Bear Stearns, and is headquartered at 30 Hudson Yards in New York. Its 1989 leveraged buyout of RJR Nabisco turned the LBO into a household phrase.

Firm Snapshot

It is no longer just a buyout shop. KKR today runs three businesses: asset management (private equity, credit, infrastructure, real estate and capital markets), insurance (Global Atlantic, acquired in 2024) and Strategic Holdings.

Joseph Bae and Scott Nuttall became co-CEOs in 2021, with Kravis and Roberts moving to co-executive chairmen.

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-69634 (status: Approved), registered 2008-10-15
  • Regulatory AUM (Form ADV): $396.78B as of 2026-09-25
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 630 private funds, of which 18 hedge funds
  • Website: kkr.com

Portfolio Structure

  • 79 positions · $4.26B reported value (Q3 2026)
  • Top 10 holdings = 98.0% of reported value
  • Largest position: BTSG (BRIGHTSPRING HEALTH SVCS INC) at 35.8%
  • Average position size: $53.88M

Sector Tilt

  • Health Care 66.8%
  • Information Technology 12.6%
  • Energy 8.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 11 new, 8 added, 10 reduced, 8 exited
  • 50 positions unchanged

Reading the 13F

Most of KKR's capital sits in unlisted companies, infrastructure and private credit, so the 13F covers only a thin slice — its public-markets and permanent-capital strategies plus the Global Atlantic insurance portfolio. Treat the holdings list as a side pocket, not the firm's main book.

The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.

Sector Allocation

Health Care 35.0%
Financials 13.5%
Technology 7.9%
Other 13.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 31.06M $819.08M 31.20%
31.20%
New
2 50.63M $392.41M 14.95%
14.95%
New
3 17.02M $335.09M 12.77%
12.77%
New
4 4.45M $177.82M 6.77%
6.77%
New
5 43.48M $159.16M 6.06%
6.06%
New
6 10.00M $118.70M 4.52%
4.52%
New
7 4.50M $89.47M 3.41%
3.41%
New
8 91.63M $71.30M 2.72%
2.72%
New
9 856.42K $68.06M 2.59%
2.59%
New
10 24.41M $54.19M 2.06%
2.06%
New
11 305.07K $53.78M 2.05%
2.05%
New
12 5.24M $43.03M 1.64%
1.64%
New
13 3.45M $25.74M 0.98%
0.98%
New
14 13.54M $19.31M 0.74%
0.74%
New
15 20.64M $18.18M 0.69%
0.69%
New
16 922.55K $17.03M 0.65%
0.65%
New
17 14.50M $15.64M 0.60%
0.60%
New
18 18.16M $14.95M 0.57%
0.57%
New
19 15.00M $14.00M 0.53%
0.53%
New
20 10.00M $11.77M 0.45%
0.45%
New
21 12.00M $11.64M 0.44%
0.44%
New
22 3.04M $11.35M 0.43%
0.43%
New
23 305.07K $11.34M 0.43%
0.43%
New
24 8.50M $8.99M 0.34%
0.34%
New
25 572.35K $7.23M 0.28%
0.28%
New
26 7.44M $7.06M 0.27%
0.27%
New
27 6.12M $6.10M 0.23%
0.23%
New
28 6.79M $5.45M 0.21%
0.21%
New
29 4.23M $3.66M 0.14%
0.14%
New
30 3.87M $3.38M 0.13%
0.13%
New
31 3.20M $3.30M 0.13%
0.13%
New
32 3.40M $2.70M 0.10%
0.10%
New
33 3.04M $2.64M 0.10%
0.10%
New
34 2.69M $2.30M 0.09%
0.09%
New
35 2.50M $2.07M 0.08%
0.08%
New
36 1.87M $1.91M 0.07%
0.07%
New
37 4.14M $1.78M 0.07%
0.07%
New
38 1.77M $1.70M 0.07%
0.07%
New
39 2.00M $1.60M 0.06%
0.06%
New
40 1.58M $1.44M 0.06%
0.06%
New
41 1.22M $1.08M 0.04%
0.04%
New
42 1.00M $931.53K 0.04%
0.04%
New
43 1.00M $820.60K 0.03%
0.03%
New
44 800.00K $795.20K 0.03%
0.03%
New
45 651.00K $697.87K 0.03%
0.03%
New
46 616.41K $690.38K 0.03%
0.03%
New
47 60.06K $629.47K 0.02%
0.02%
New
48 610.00K $620.98K 0.02%
0.02%
New
49 675.00K $595.69K 0.02%
0.02%
New
50 510.00K $487.71K 0.02%
0.02%
New

FAQ

What did Kohlberg Kravis Roberts & Co. L.P. buy in 2023-Q3?

In its 2023-Q3 13F filing, Kohlberg Kravis Roberts & Co. L.P. reported 55 equity positions worth $2.62B in aggregate; its largest disclosed positions were BBIO ($819.08M), BV ($392.41M), FSK ($335.09M).

How large is Kohlberg Kravis Roberts & Co. L.P.'s portfolio?

Kohlberg Kravis Roberts & Co. L.P. reported $2.62B of long equity holdings across 55 positions as of 2023-Q3. Top-10 holdings account for 87.1% of reported value.

What is Kohlberg Kravis Roberts & Co. L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kohlberg-kravis-roberts-and/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →